Bronchoscopic Sampling of Drug Concentrations: Penetration to Tissue Is the Issue

American Journal of Respiratory and Critical Care Medicine

Volumn 168, Issue 11, 2003, Pages 1263-1265

  Fish, Douglas N ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM; LEVOFLOXACIN; MACROLIDE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; BODY FLUID; BRONCHOSCOPY; DRUG PENETRATION; DRUG RESPONSE; EDITORIAL; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SAMPLING; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; BRONCHI; BRONCHOSCOPY; HUMANS; TISSUE DISTRIBUTION;

EID: 0344825066     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2309013     Document Type: Editorial

References (16)

1. Siegel RE. The significance of serum vs. tissue levels of antibiotics in the treatment of penicillin-resistant Streptococcus pneumoniae and community-acquired pneumonia: are we looking in the wrong place? Chest 1999;116:535-538.
2. Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother 1992;36:1171-1175.
3. Yamazaki K, Ogura S, Ishizaka A, Oh-hara T, Nishimura M. Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid. Am J Respir Crit Care Med 2003;168:1304-1307.
4. Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrob Agents Chemother 1992;36:1176-1180.
5. Thornsberry C, Sahm DF, Kelly LJ, Critchley IA, Jones ME, Evangelista AT, Karlowsky JA. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae. and Moraxella catarrhalis in the United States: results from the TRUST surveillance program, 1999-2000. Clin Infect Dis 2002;34(Suppl 1):S4-S16.
6. Zhanel GG, Palatnick L, Nichol KA, Bellyou T, Low DE, Hoban DJ. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997-2002. Antimicrob Agents Chemother 2002;47:1867-1874.
7. MacGowan AP, Wootton M, Holt HA. The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility. J Antimicrob Chemother 1999;43:345-349.
8. Zhanel GG, Walters M, Laing N, Hoban DJ. In vitro pharmacodynamic modeling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae. J Antimicrob Chemother 2001;47:435-440.
9. Conte JE Jr, Golden JA, Kipps J, Zurlinden E. Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother 2002;46:1475-1480.
10. Cruciani M, Gatti G, Lazzarini L, Furlan G, Broccali G, Malena M, Franchini C, Concia E. Penetration of vancomycin into human lung tissue. J Antimicrob Chemother 1996;38:865-869.
11. Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH. Linezolid Nosocomial Pneumonia Study Group: continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 2003;25: 980-992.
12. Gotfried MH, Danziger LH, Rodvold KA. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest 2001;119:1114-1122.
13. Dunbar LM, Wunderink RG, Habib MP, Smith LG, Tennenberg AM, Khashab MM, Wiesinger BA, Xiang JX, Zadeikis N, Kahn JB. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003;37:752-760.
14. Preston SL, Drusano GL, Berman AL, Fowler CL, Chow AT, Dornseif B, Reichl V, Natarajan J, Corrado M. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 1998;279:125-129.
15. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-10.
16. Wright DH, Brown GH, Peterson ML, Rotschafer JC. Application of fluoroquinolone pharmacodynamics. J Antimicrob Chemother 2000;46: 669-683.